Carbohydrate-mediated modulation of NK cell receptor function: Structural and functional influences of heparan sulfate moieties expressed on NK cell surface

Frontiers in Oncology

Volumn 4 JUL, Issue , 2014, Pages

  Brusilovsky, Michael ^a   Radinsky, Olga ^a   Yossef, Rami ^a   Campbell, Kerry S ^b   Porgador, Angel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Heparan sulfate; Heparan sulfate proteoglycans; KIR2DL4; Natural cytotoxicity receptors; Natural killer cells; NKp30; NKp44; NKp46

Indexed keywords

HEPARAN SULFATE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL KILLER CELL RECEPTOR;

ARTICLE; CYTOTOXICITY; IMMUNE RESPONSE; NATURAL KILLER CELL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

EID: 84904672610     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00185     Document Type: Article

References (31)

1. Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer (2002) 2:521-8. doi:10.1038/nrc842
2. Hecht ML, Rosental B, Horlacher T, Hershkovitz O, De Paz JL, Noti C, et al. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J Proteome Res (2009) 8:712-20. doi:10.1021/pr800747c
3. Sasisekharan R, Venkataraman G. Heparin and heparan sulfate: biosynthesis, structure and function. Curr Opin Chem Biol (2000) 4:626-31. doi:10.1016/S1367-5931(00)00145-9
4. Esko JD, Lindahl U. Molecular diversity of heparan sulfate. J Clin Invest (2001) 108:169-73. doi:10.1172/JCI13530
5. Sanderson RD, Yang Y, Kelly T, Macleod V, Dai Y, Theus A. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies. J Cell Biochem (2005) 96:897-905. doi:10.1002/jcb.20602
6. Dennissen MA, Jenniskens GJ, Pieffers M, Versteeg EM, Petitou M, Veerkamp JH, et al. Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J Biol Chem (2002) 277:10982-6. doi:10.1074/jbc.M104852200
7. Bernsen MR, Smetsers TF, Van De Westerlo E, Ruiter DJ, Hakansson L, Gustafsson B, et al. Heparan sulphate epitope-expression is associated with the inflammatory response in metastatic malignant melanoma. Cancer Immunol Immunother (2003) 52:780-3. doi:10.1007/s00262-003-0421-8
8. Smetsers TF, Van De Westerlo EM, Ten Dam GB, Clarijs R, Versteeg EM, Van Geloof WL, et al. Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma. Cancer Res (2003) 63:2965-70.
9. Jayson GC, Lyon M, Paraskeva C, Turnbull JE, Deakin JA, Gallagher JT. Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem (1998) 273:51-7. doi:10.1074/jbc.273.1.51
10. Blackhall FH, Merry CL, Davies EJ, Jayson GC. Heparan sulfate proteoglycans and cancer. Br J Cancer (2001) 85:1094-8. doi:10.1054/bjoc.2001.2054
11. Cagnano E, Hershkovitz O, Zilka A, Bar-Ilan A, Golder A, Sion-Vardy N, et al. Expression of ligands to NKp46 in benign and malignant melanocytes. J Invest Dermatol (2008) 128:972-9. doi:10.1038/sj.jid.5701111
12. Brusilovsky M, Rosental B, Shemesh A, Appel MY, Porgador A. Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands. J Immunotoxicol (2012) 9:267-74. doi:10.3109/1547691X.2012.675366
13. Koch J, Steinle A, Watzl C, Mandelboim O. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol (2013) 34:182-91. doi:10.1016/j.it.2013.01.003
14. Kruse PH, Matta J, Ugolini S, Vivier E. Natural cytotoxicity receptors and their ligands. Immunol Cell Biol (2014) 92:221-9. doi:10.1038/icb.2013.98
15. Cerwenka A, Lanier LL. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev (2001) 181:158-69. doi:10.1034/j.1600-065X.2001.1810113.x
16. Higai K, Suzuki C, Imaizumi Y, Xin X, Azuma Y, Matsumoto K. Binding affinities of NKG2D and CD94 to sialyl Lewis X-expressing N-glycans and heparin. Biol Pharm Bull (2011) 34:8-12. doi:10.1248/bpb.34.8
17. Higai K, Matsumoto K. [Glycan ligand specificity of killer lectin receptors]. Yakugaku Zasshi (2012) 132:705-12. doi:10.1248/yakushi.132.705
18. Brusilovsky M, Cordoba M, Rosental B, Hershkovitz O, Andrake MD, Pecherskaya A, et al. Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses. J Immunol (2013) 191:5256-67. doi:10.4049/jimmunol.1302079
19. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med (1999) 189:1093-100. doi:10.1084/jem.189.7.1093
20. Rosental B, Brusilovsky M, Hadad U, Oz D, Appel MY, Afergan F, et al. Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J Immunol (2011) 187:5693-702. doi:10.4049/jimmunol.1102267
21. Matta J, Baratin M, Chiche L, Forel JM, Cognet C, Thomas G, et al. Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. Blood (2013) 122:394-404. doi:10.1182/blood-2013-01-481705
22. Hershkovitz O, Jivov S, Bloushtain N, Zilka A, Landau G, Bar-Ilan A, et al. Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry (2007) 46:7426-36. doi:10.1021/bi7000455
23. Carey DJ. Syndecans: multifunctional cell-surface co-receptors. Biochem J (1997) 327(Pt 1):1-16.
24. Fadnes B, Husebekk A, Svineng G, Rekdal O, Yanagishita M, Kolset SO, et al. The proteoglycan repertoire of lymphoid cells. Glycoconj J (2012) 29:513-23. doi:10.1007/s10719-012-9427-9
25. Bass MD, Humphries MJ. Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling. Biochem J (2002) 368:1-15. doi:10.1042/BJ20021228
26. Beauvais DM, Rapraeger AC. Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol (2004) 2:3. doi:10.1186/1477-7827-2-3
27. Morgan MR, Humphries MJ, Bass MD. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol (2007) 8:957-69. doi:10.1038/nrm2289
28. Elfenbein A, Lanahan A, Zhou TX, Yamasaki A, Tkachenko E, Matsuda M, et al. Syndecan 4 regulates FGFR1 signaling in endothelial cells by directing macropinocytosis. Sci Signal (2012) 5:ra36. doi:10.1126/scisignal.2002495
29. Avril T, North SJ, Haslam SM, Willison HJ, Crocker PR. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression. J Leukoc Biol (2006) 80:787-96. doi:10.1189/jlb.1005559
30. Bloushtain N, Qimron U, Bar-Ilan A, Hershkovitz O, Gazit R, Fima E, et al. Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46. J Immunol (2004) 173:2392-401. doi:10.4049/jimmunol.173.4.2392
31. Zilka A, Landau G, Hershkovitz O, Bloushtain N, Bar-Ilan A, Benchetrit F, et al. Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46. Biochemistry (2005) 44:14477-85. doi:10.1021/bi051241s